Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Journal of the American Society of Nephrology : JASN|November 3, 2018
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry DiseaseMalte Lenders, Leon Paul Neußer, Michael Rudnicki, et al.
Cell Reports. Medicine|October 10, 2023
MesoGraph: Automatic profiling of mesothelioma subtypes from histological imagesMark Eastwood, Heba Sailem, Silviu Tudor Marc, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical responseMaria Aanesland Dahle, Jan-Lukas Førde, Eivind Valen Egeland, et al.
Artificial Intelligence in Medicine|September 6, 2023
Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology dataMark Eastwood, Silviu Tudor Marc, Xiaohong Gao, et al.
Trends in Pharmacological Sciences|September 24, 2024
How can quantum computing be applied in clinical trial design and optimization?Hakan Doga, Aritra Bose, M Emre Sahin, et al.
Orphanet Journal of Rare Diseases|June 18, 2015
A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 diseaseAnne-Katrin Giese, Hermann Mascher, Ulrike Grittner, et al.
Clinical Kidney Journal|May 29, 2015
Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA geneJan Lukas, Joan Torras, Itziar Navarro, et al.
Frontiers in Microbiology|July 30, 2019
Regulation of the Phytoplankton Heme b Iron Pool During the North Atlantic Spring BloomEvangelia Louropoulou, Martha Gledhill, Thomas J Browning, et al.
International Journal of Pharmaceutics|December 18, 2023
Development of nanoparticles based on amphiphilic cyclodextrins for the delivery of active substancesLuc Augis, Ingeborg Nerbø Reiten, Jan-Lukas Førde, et al.
Plos One|November 27, 2013
Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patientsArndt Rolfs, Anne-Katrin Giese, Ulrike Grittner, et al.
Pageof 17